1-3 of 3
Ann E.-J. Lin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interaction of a Novel Signaling Protein (AHI-1) with BCR-ABL Modulates BCR-ABL Transforming Activity and Imatinib Response of Chronic Myeloid Leukemia Progenitor Cells.

Yun Zhao, PhD, Leon Zhou, MS, Ashley Ringrose, BS, Ann E.-J. Lin, BS, Erin Kennah, MS, Guoqing Sheng, PhD, Xiao-Jiang Li, PhD, Ali Turhan, PhD, Xiaoyan Jiang, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 467.
https://doi.org/10.1182/blood.V110.11.467.467
Published: 2007
Journal Articles

Deregulated Expression of a Novel Oncogene, Ahi-1, in Murine Hematopoietic Cells Confers a Proliferative Advantage In Vitro and Leukemogenic Activity In Vivo and Enhances the Effects of BCR-ABL.

Leon Zhou, Ashley Ringrose, Ann E.-J. Lin, Xiaoyan Jiang, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 388.
https://doi.org/10.1182/blood.V108.11.388.388
Published: 2006
Journal Articles

Stable Suppression of a Novel Oncogene, AHI-1, in Human Cutaneous T-Cell Leukemia Cells Normalizes Its Transforming Activity In Vitro and In Vivo and Aberrant Expression of AHI-1 Is Also Present in Leukemic Sezary Cells from Patients with Sezary Syndrome.

Ashley Ringrose, Youwen Zhou, MD, Emily Pang, Ann E.-J. Lin, Xiao-Jiang Li, PhD, Irene Li, Andrew Weng, MD, PhD, Xiaoyan Jiang, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2605.
https://doi.org/10.1182/blood.V106.11.2605.2605
Published: 2005